Definition:
The Sleep Aids market encompasses a diverse array of over-the-counter (OTC) medications and supplements designed to aid individuals in managing sleep-related disorders, including insomnia, sporadic sleep disruptions, and jetlag resulting from adjusting to different time zones. This market includes products containing ingredients such as Doxylamine Succinate, Diphenhydramine, Melatonin, and herbal remedies. Notable sleep aid products include Natrol Melatonin, Vitafusion, Alteril, Unisom SleepTabs, and Kalms. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional information:
The Sleep Aids market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
The Sleep Aids market in Iran is experiencing significant growth and development.
Customer preferences: Iranians are increasingly recognizing the importance of a good night's sleep and are seeking solutions to address sleep-related issues. As a result, there is a growing demand for sleep aids in the country. Customers are looking for products that can help them improve the quality of their sleep and address common sleep disorders such as insomnia and sleep apnea.
Trends in the market: One of the key trends in the Sleep Aids market in Iran is the increasing popularity of natural and herbal sleep aids. Customers are becoming more conscious about the potential side effects of pharmaceutical sleep aids and are opting for natural alternatives. This trend is driven by a growing interest in holistic wellness and a desire to use products that are perceived as safer and more sustainable. Another trend in the market is the rise of wearable sleep technology. Customers are increasingly using wearable devices such as smartwatches and sleep trackers to monitor their sleep patterns and identify potential sleep disturbances. This trend is fueled by the growing adoption of technology and the desire to take a proactive approach towards improving sleep health.
Local special circumstances: Iran has a relatively young population, with a significant portion of the population being under the age of 35. This demographic trend is driving the demand for sleep aids, as younger individuals are more likely to experience sleep-related issues due to their lifestyle choices, such as irregular sleep schedules and high levels of stress. Additionally, the urbanization and modernization of Iranian society have led to an increase in sedentary lifestyles and higher levels of stress, further contributing to sleep disorders.
Underlying macroeconomic factors: The Sleep Aids market in Iran is also influenced by macroeconomic factors. The country has been experiencing economic growth in recent years, which has resulted in increased disposable income and higher purchasing power among consumers. This has allowed more individuals to afford sleep aids and invest in their sleep health. Furthermore, the healthcare infrastructure in Iran has been improving, with a greater emphasis on preventive care and wellness. This has led to increased awareness and education about the importance of sleep and the availability of sleep aids in the market. In conclusion, the Sleep Aids market in Iran is developing due to changing customer preferences, including a growing demand for natural and herbal sleep aids, as well as the adoption of wearable sleep technology. Local special circumstances, such as a young population and urbanization, further contribute to the growth of the market. Additionally, underlying macroeconomic factors, such as economic growth and improved healthcare infrastructure, play a significant role in the development of the market.
Most recent update: Mar 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights